Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication

Nadyr Damasceno,1 Soraya Horowitz,2 Eduardo Damasceno31,2Ophthalmology Department, Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil; 3Department of Ophthalmology, Universidade Federal Fluminense, Niteroi, BrazilAbstract: The authors describe one case of anterior uveitis after treatment of age-re...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Damasceno N, Horowitz S, Damasceno E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/28a84ef5adf246ce964150540090ded2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:28a84ef5adf246ce964150540090ded2
record_format	dspace
spelling	oai:doaj.org-article:28a84ef5adf246ce964150540090ded22021-12-02T04:25:41ZAnterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication1177-54671177-5483https://doaj.org/article/28a84ef5adf246ce964150540090ded22012-07-01T00:00:00Zhttp://www.dovepress.com/anterior-uveitis-after-treatment-of-age-related-macular-degeneration-w-a10564https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Nadyr Damasceno,1 Soraya Horowitz,2 Eduardo Damasceno31,2Ophthalmology Department, Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil; 3Department of Ophthalmology, Universidade Federal Fluminense, Niteroi, BrazilAbstract: The authors describe one case of anterior uveitis after treatment of age-related macular degeneration with both antiangiogenic drugs: ranibizumab and bevacizumab. The case is described as a complication of ranibizumab and bevacizumab due to an inflammatory process. Several reasons are suggested to explain this possibility, and the authors conclude that the main cause remains unknown.Keywords: antiangiogenic agent, complications, ocular inflammatory process, ranibizumab, bevacizumab, anterior uveitisDamasceno NHorowitz SDamasceno EDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 1201-1205 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Damasceno N Horowitz S Damasceno E Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
description	Nadyr Damasceno,1 Soraya Horowitz,2 Eduardo Damasceno31,2Ophthalmology Department, Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil; 3Department of Ophthalmology, Universidade Federal Fluminense, Niteroi, BrazilAbstract: The authors describe one case of anterior uveitis after treatment of age-related macular degeneration with both antiangiogenic drugs: ranibizumab and bevacizumab. The case is described as a complication of ranibizumab and bevacizumab due to an inflammatory process. Several reasons are suggested to explain this possibility, and the authors conclude that the main cause remains unknown.Keywords: antiangiogenic agent, complications, ocular inflammatory process, ranibizumab, bevacizumab, anterior uveitis
format	article
author	Damasceno N Horowitz S Damasceno E
author_facet	Damasceno N Horowitz S Damasceno E
author_sort	Damasceno N
title	Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
title_short	Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
title_full	Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
title_fullStr	Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
title_full_unstemmed	Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
title_sort	anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/28a84ef5adf246ce964150540090ded2
work_keys_str_mv	AT damascenon anterioruveitisaftertreatmentofagerelatedmaculardegenerationwithranibizumabandbevacizumabuncommoncomplication AT horowitzs anterioruveitisaftertreatmentofagerelatedmaculardegenerationwithranibizumabandbevacizumabuncommoncomplication AT damascenoe anterioruveitisaftertreatmentofagerelatedmaculardegenerationwithranibizumabandbevacizumabuncommoncomplication
_version_	1718401235975929856

Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication

Ejemplares similares